Skip to main content

Heart Failure (CHF/Congestive Heart Failure)

  • Chapter
  • First Online:
Clinical Guide to Cardiovascular Disease
  • 1462 Accesses

Abstract

Consider reversible causes, including:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Guidelines

Patient Information

Heart Diagrams

General

General: Heart Failure

ACE Inhibitors

Aldosterone Receptor Antagonists

ARBS

Daily Weights

Digoxin

Diuretics

Heart Rhythm Disturbances

How Is Heart Failure Diagnosed?

How to Limit Fluids

How to Limit Sodium

Leg Edema

Living with Heart Failure

Lifestyle Changes

Managing Other Diseases

Medicines that Slow Heart Failure

Medicines to Avoid

Shortness of Breath

Sleep APNEA

Understanding Heart Failure Symptoms

Vasodilators

Professional Information

History

Review

Review

Review: Acute HF in Africa

Review: ARB/Neprilysin Inhibitor

Review: Cardiomyopathies

Review: Classification and Pathophysiology

Review: Drugs

Review: from Acute Decompensated to Chronic Heart Failure

Review: Gene Therapy

Review: HFpEF Phenotypes

Review: LCZ696/Entresto (Opinion)

Review: LVAD

Review: Management Mechanisms

Review: Pharmacotherapy

Review: Stem Cell/Regenerative RX

Review: Treatment

ACE Inhibitors

Acute Myocardial Infarction

Acute Myocardial Infarction

Alcohol/Mortality

Alcohol/Risk

Alcohol/Risk

Aldosterone Antagonism (Spironolactone): Topcat Study

Anemia and Outcomes: HFpEF Versus HFrEF

Angiotensin: Neprilysin Inhibition

Angiotensin: Neprilysin Inhibition

Anthracycline

Anthracycline

Aquapharesis Versus Diuretics

ARBS

Atrial Fibrillation

Atrial Fibrillation

Atrial Fibrillation

Atrial Fibrillation (New Onset): HF Progression

Atrial Fibrillation: Rhythm Control

Atrial Fibrillation: Rhythm Versus Rate Control

Bariatric Surgery

Bariatric Surgery

Beta-Blockers

Beta-Blockers: Tolerability/Feasibility in HFrEF Vs HFpEF

BNP: Guided Treatment

BNP: Predictor of Worsening HF

BNP: Prognosis IN LVrEF/LVpEF HF

CAD (Commentary)

Cardiohepatic Interactions

Cardiorenal Syndrome

Central Sleep APNEA

Cobalt Toxicity/Hip Prosthesis

Comorbidities

Comorbidities (Multimorbidity)

Comorbidities: Non-cardiac in HFrEF

Cognitive Impairment

COPD

CPAP

CRT

CRT

CRT

CRT: RV Function/Outcomes

CRT: Response/QRS Widening

CRT-D: Survival

Depression

Diabetes Mellitus: Effect on Outcomes

Diabetes Mellitus

Diet: Sodium

Digoxin: Increased Risk (Review/Metaanalysis)

Digoxin

Digoxin

Digoxin

Diuretics

Diuretics

Diuresis: Hemoconcentration-Directed

Echo-dopper Hemodynamics

Economic Burden

Eplerenone: HF/Rehospitalization

Exercise Testing: Predictors of Death in HFrEF

Exercise Training

Exercise Training: HF-Action Trial

Exercise Training

Galactin-3

Genetics: Causes

Heart Rate Range (Ambulatory ECG)/Prognosis

Heart Rate: Prognostic Risk Factor

Heart Rate at Time of Discharge: Risk for Death/Rehospitalization

HFpEF: Diabetes Mellitus

HFpEF: Doppler Echo

HFpEF: Echo Evaluation of LV Diastolic Function

HFpEF: Left Atrium

HFpEF: Misconceptions

HFpEF: Mitral Regurgitation

HFpEF: Review

HFpEF: Prevalence, Clinical Characteristics, Outcomes

HFpEF: RV Dysfunction

HFpEF: RV Dysfunction

HFpEF: Targeted Phenotypic Therapies

HFpEF: Trends

HFrEF: Mitral Regurgitation

High Output Failure: Renal Cell Carcinoma

Histamine H2 Receptor Antagonists: Decreased HF Risk

HIV

Hydralazine-Isosorbide Dinitrate in African-Americans

Hydralazine-Isosorbide Dinitrate in African-Americans: Follow Up

Hyperglycemia

Hypocalcemia

Hypocalcemia

ICD: Adherence to Recommended Medications Before Implanation

ICD

Imaging

Influenza Vaccination

Insomnia

Intestinal Blood Flow

Iron Deficiency

Iron Deficiency

Iron Therapy

Ivabradine

Ivabradine: Collateral Coronary Circulation

Ivabradine: HR Rate Slowing Effect on Symptoms with HFpEF

Ivabradine: LV Afterload Reduction

Ivabradine: Outcomes

Kidney Disease

Lifestyle Risk Factors

Liver Dysfunction

LCZ696 (Angiotensin Receptor-Neprilysin Inhibitor)

LCZ696 (Angiotensin Receptor-Neprilysin Inhibitor)

Left Atrial Function

LVAD: Post-implant Management

Metabolic Impairment

Metabolic Syndrome

Minnesota Living with Heart Failure Questionnaire

Mitral Valve Flow Pattern in Diastolic Dysfunction

Mitral Valve Repair: Dilated Cardiomyopathies

Monitoring: Remote

Monitoring: Wireless Pulmonary Artery Pressure

Monitoring: Wireless Pulmonary Artery Pressure in HFpEF

Myocardial Fibrosis

Myocardial Interstitium

Neurohormone/Sex Differences: Outcomes

Obesity/Abdominal Adiposity/Overweight: Risk Factors

Obesity: Paradox

Obesity: Risk Factor

Obstructive Sleep Apnea

Omecamtiv Mecarbil

Outcomes: Stratified by Cardiomyopathy Etiology

Outcomes: Collaborative Care

Outcomes: Readmission Rates/Predictors

Outcomes: Rehospitalization Reduction Strategies

Outcomes: Rehospitalization Reduction Strategies

Pathophysiology

Performance Measures: ACCF/AHA/AMA- PCPI

Pericardial Effusion

Phenotypes: Sex Differences

Pregnancy

Prevention

Pulmonary Hypertension

Pulse Pressure Decrease: Prognosis in HFrEF Versus HFpEF

PVCS: LVEF/HF/Mortality

QOL: Rural Patients

Rehospitalization

Rehospitalization: Risk Factors

Relapsing Catastrophic Antiphospholipid Antibody Syndrome (Case Report)

Remodeling

Remote Monitoring

Renal Dysfunction: Outcomes

Renal Insufficiency: Treatment in HF

Scorpion Envenomation: Pulmonary Edema

Seattle Heart Failure Model (Projected Survival Calculator)

Serelaxin

Serelaxin

Serelaxin

Sinus Node Function: Remodeling

Skeletal Muscle Wasting

Sleep-Disordered Breathing

Socioeconomic Status/Outcomes

Spironolactone

Sodium Nitrite Infusion

Stem Cell/Regenerative RX: Metaanalysis

ST2 Assay

Strategies for Reducing Readmissions

Systemic Arterial Hypertension

Thromboembolism Risk

Transitional Care to Prevent Readmissions

Tricuspid Regurgitation: Impact on Survival

Ularitide

Unidirectional L-R Interatrial Shunting

Uric Acid

Vagal Nerve Stimulation: Chronic Therapy for HFrEF

Valsalva Response

Updates and More

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London

About this chapter

Cite this chapter

Friedewald, V.E. (2016). Heart Failure (CHF/Congestive Heart Failure). In: Clinical Guide to Cardiovascular Disease. Springer, London. https://doi.org/10.1007/978-1-4471-7293-2_52

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-7293-2_52

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-7291-8

  • Online ISBN: 978-1-4471-7293-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics